NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,814,763 | -15.3% | 3,738,849 | +3.7% | 0.00% | – |
| Q2 2023 | $13,948,734 | +52.5% | 3,604,324 | +9.2% | 0.00% | – |
| Q1 2023 | $9,144,867 | +51.8% | 3,301,396 | -1.3% | 0.00% | – |
| Q4 2022 | $6,023,382 | -11.5% | 3,346,323 | +4.3% | 0.00% | – |
| Q3 2022 | $6,804,000 | -22.3% | 3,209,494 | -1.4% | 0.00% | – |
| Q2 2022 | $8,758,000 | +67.3% | 3,256,032 | +170.0% | 0.00% | – |
| Q1 2022 | $5,234,000 | -19.3% | 1,205,986 | -3.7% | 0.00% | – |
| Q4 2021 | $6,485,000 | -14.0% | 1,251,848 | +1.9% | 0.00% | – |
| Q3 2021 | $7,542,000 | -25.1% | 1,228,288 | +23.2% | 0.00% | – |
| Q2 2021 | $10,068,000 | – | 996,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
| AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
| Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
| Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
| Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
| HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
| RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |